Startups
Aspiring to add 10 years to healthy human lifespan, starting with cellular reprogramming, autophagy, & plasma-inspired therapeutics
Overview
Location
United States, California, San Francisco
Employees
11-50
Total raised
$180M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 25, 2026 | Индустрия долголетия привлекла миллиарды — теперь ее разработки проверяют на людях | Стартапы в сфере долголетия привлекли миллиарды долларов на разработки, призванные замедлить связанные со старением процессы. В ближайшие 12−18 месяцев несколько компаний планируют начать первые испытания на людях или представить ранние кли... |
| Feb 3, 2026 | Umanitek launches Guardian Agent to tackle AI hallucinations, deepfakes and identity abuse Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE Cookies | Artificial intelligence harm reduction company Umanitek AG today announced the launch of Guardian Agent, an AI identity protection platform designed to combat large language model hallucinations, deepfakes, impersonation and threats to digi... |
| 2026 | The Longevity Startup That Already Has the Data Altos Labs Is Seeking: Hidden in Plain Sight | While Jeff Bezos and Sam Altman fund billion-dollar moonshots in cellular rejuvenation, one biotechnology company has been quietly treating patients for seven years, accumulating the kind of clinical data that typically takes a decade and h... |
| Mar 23, 2024 | Sam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences | Redeem now Sam Altman is already a tech titan. Somehow, at 38, he's been coding for three decades, and with the advent of ChatGPT and (more recently) Sora, he's quickly amassed nearly as much hype and influence as Elon Musk and Mark Zuckerb... |
| Dec 7, 2023 | The tech billionaires trying to hack longevity and live forever | From Sam Altman (from top left, clockwise) to Peter Thiel, Mark Zuckerberg, Jeff Bezos, and Sergey Brin, many of the world's wealthiest billionaires seem to be on a quest for the fountain of youth. Lucy Nicholson/Reuters/Marco Bello/Getty I... |
| Mar 9, 2023 | OpenAI CEO Sam Altman takes diabetes drug metformin as part of his anti-aging routine | OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. His anti-aging regimen also includes healthy eating, exercising, and getting enough sleep. Advertisement Sam Altman, the CEO of ChatGPT-maker OpenAI, takes a diabet... |
| Mar 9, 2023 | OpenAI's 37-year-old CEO bet $180 million on a little-known biotech startup that's trying to help people live 10 years longer | Sam Altman, CEO of OpenAI, walks from lunch during the Allen & Company Sun Valley Conference on July 06, 2022 in Sun Valley, Idaho. Kevin Dietsch/Getty Images Redeem now From Jeff Bezos to Jack Dorsey, billionaires are using their wealt... |
| Mar 9, 2023 | Sam Altman gave us ChatGPT. Now he wants us to defy death. | Sam Altman. Drew Angerer/Getty Redeem now Sam Altman put $180 million into Retro Biosciences, a company that aims to delay death by 10 years. Altman's interest in longevity research dates back at least eight years, per the MIT Technology Re... |
| Mar 8, 2023 | OpenAI CEO Sam Altman takes diabetes drug metformin as part of his anti-aging routine | OpenAI CEO Sam Altman said he takes diabetes drug metformin as part of his anti-aging regime. Drew Angerer/Getty Images Redeem now OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. His anti-aging regimen also inclu... |
Show more
Reviews 0
FAQ about Retro Biosciences
How much funding has Retro Biosciences raised?
Retro Biosciences has raised $180M in total across 1 funding round.
What has the press written about Retro Biosciences?
Parsers VC has collected 13 articles mentioning Retro Biosciences, among them “Индустрия долголетия привлекла миллиарды — теперь ее разработки проверяют на людях” (Aug 25, 2026) and “Umanitek launches Guardian Agent to tackle AI hallucinations, deepfakes and identity abuse Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE Cookies” (Feb 3, 2026).
Is Retro Biosciences still active?
Retro Biosciences is probably closed: its latest activity on Parsers VC dates from Aug 27, 2026.